The current knowledge on NRP1 expression in cancer provides an early step indicating that the potential of NRP1 as a biomarker should be further investigated in large tumor cohorts with special attention to the possible differences among distinct molecular subgroups within each tumor type. This evidence concerns the gene NRP1 and neoplasm.